Determination and clinical significance of bone pseudoprogression in hormone receptor-positive metastatic breast cancer
Background: 99m Technetium labeled methylene diphosphonate bone scans (BSs) are commonly used to monitor disease progression in bone for patients with metastatic breast cancer (MBC). However, new BS lesions may represent osteoblastic bone healing, which we now define as bone pseudoprogression. In th...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publishing
2021-06-01
|
| Серии: | Therapeutic Advances in Medical Oncology |
| Online-ссылка: | https://doi.org/10.1177/17588359211022881 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|